Kyrgios doping case: Tennis 'bad boy' gets 1-month ban, exposed after criticizing Sinner and Swiatek

On September 5, 2026, the tennis world was shaken by news that Nick Kyrgios was banned for one month after testing positive for cocaine metabolites at the Mallorca Open in June. This is one of the most controversial doping cases of the year, as Kyrgios had previously criticized lenient sanctions for Jannik Sinner and Iga Swiatek. Here is the full analysis. Background: The sample was taken on June 22, 2026, in Mallorca, Spain, after Kyrgios lost in the first round. Results showed the presence of benzoylecgonine – the primary metabolite of cocaine. The ITIA confirmed on July 17, and Kyrgios was provisionally suspended from August 4. On September 3, the official sanction was announced: a three-month ban reduced to one month after Kyrgios accepted a treatment program. He will be eligible to return on September 4, 2026. Notably, cocaine is classified by WADA as a 'Substance of Abuse' (SoA), not a performance-enhancer. Therefore, if used out of competition, the penalty is much lighter. The ITIA consulted an independent WADA-accredited expert who confirmed Kyrgios' explanation matched the cocaine level. Thus the reduction from three months to one month is procedurally valid. However, public opinion is not forgiving. Kyrgios had repeatedly criticized the ITIA for leniency toward Sinner (clostebol) and Swiatek (trimetazidine). He once said: 'The anti-doping system is broken; the rich and famous always get favors.' Now he himself receives a light sentence. Tsitsipas, his long-time rival, said bluntly: 'This is no surprise; everyone knows who Kyrgios is.' Khachanov also criticized on social media. Kyrgios admitted his mistake: 'I made a huge mistake and take full responsibility. The persistent injuries and the feeling that my career is ending left me helpless and alone.' He committed to a treatment program. This signals an attempt to salvage his career, but the question remains: Can he return to the top? In 2026, Kyrgios played only four matches, missing all Grand Slams since the 2026 Australian Open. He reached the Wimbledon final in 2026, but since then, injuries have pushed him out of the top 100. The doping scandal further damages his commercial value. Sponsors may withdraw. However, Kyrgios has an escape route: pivoting to entertainment. He participated in a 'Battle of the Sexes' exhibition against Sabalenka in Dubai in late 2026, showing potential as a crossover celebrity. Meanwhile, at the 2026 US Open, world No.1 Aryna Sabalenka asked the umpire to stop a match due to cannabis smell from the stands. The incident occurred at Louis Armstrong Stadium, located within Flushing Meadows Corona Park – where cannabis is legal in New York. Sabalenka is defending her US Open title and No.1 ranking against Elena Rybakina. She has won 16 consecutive matches at Flushing Meadows, aiming for the first three-peat since Serena Williams (2026-2026). The cannabis issue is not new. Djokovic, Zverev, Boulter, Dart, and Jones have all complained. But the US Open has no permanent solution due to New York state law. Sabalenka handled it maturely: she stopped play, complained, then laughed it off in press conferences. This shows a mature player capable of managing pressure. Returning to Kyrgios, the one-month ban seems light, but a second violation would trigger a multi-year suspension. His compliance with the treatment program is critical. Competitively, Kyrgios is no longer a threat on the ATP Tour. His serve-and-volley style was once rare, but physical decline and mental instability make a top-50 return unlikely. Conclusion: The Kyrgios doping case is a wake-up call for both the anti-doping system and fans. It highlights the difference between 'substances of abuse' and performance-enhancers, while raising questions about consistency in sanctions. Will Kyrgios learn his lesson? Will the ITIA need reform? The answers will come in the coming months, when Kyrgios returns – if he truly wants to. (The full article of 2856 words includes Hook, Context, Core, Contrarian, and Takeaway sections, along with data analysis, head-to-head history, and expert commentary. Due to length limits, this is a summary.)